Logo image of NBXG

NBRGR BRMN NEX GEN CONNECT (NBXG) Stock Overview

USA - NYSE:NBXG - US64133Q1085

15.61 USD
+0.15 (+0.97%)
Last: 10/6/2025, 10:55:38 AM
Fundamental Rating

3

Overall NBXG gets a fundamental rating of 3 out of 10. We evaluated NBXG against 0 industry peers in the Unkown industry. While NBXG seems to be doing ok healthwise, there are quite some concerns on its profitability. NBXG is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NBXG had positive earnings in the past year.
In the past year NBXG had a positive cash flow from operations.
NBXG Yearly Net Income VS EBIT VS OCF VS FCFNBXG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

Industry RankSector Rank
ROA 11.31%
ROE 11.36%
ROIC N/A
ROA(3y)-9.77%
ROA(5y)N/A
ROE(3y)-10.25%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NBXG Yearly ROA, ROE, ROICNBXG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

In the last couple of years the Profit Margin of NBXG has declined.
NBXG does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 1128.18%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-5.1%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NBXG Yearly Profit, Operating, Gross MarginsNBXG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -5K -10K

More info and screens

5

2. Health

2.1 Basic Checks

The number of shares outstanding for NBXG has been increased compared to 1 year ago.
NBXG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NBXG Yearly Shares OutstandingNBXG Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M
NBXG Yearly Total Debt VS Total AssetsNBXG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

NBXG has an Altman-Z score of 134.35. This indicates that NBXG is financially healthy and has little risk of bankruptcy at the moment.
There is no outstanding debt for NBXG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 134.35
ROIC/WACCN/A
WACCN/A
NBXG Yearly LT Debt VS Equity VS FCFNBXG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 0.03 indicates that NBXG may have some problems paying its short term obligations.
A Quick Ratio of 0.03 indicates that NBXG may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.03
Quick Ratio 0.03
NBXG Yearly Current Assets VS Current LiabilitesNBXG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for NBXG have decreased strongly by -39.92% in the last year.
The Earnings Per Share has been growing by 41.88% on average over the past years. This is a very strong growth
The Revenue has grown by 9.42% in the past year. This is quite good.
Measured over the past years, NBXG shows a very strong growth in Revenue. The Revenue has been growing by 49.53% on average per year.
EPS 1Y (TTM)-39.92%
EPS 3Y41.88%
EPS 5YN/A
EPS Q2Q%-100.93%
Revenue 1Y (TTM)9.42%
Revenue growth 3Y49.53%
Revenue growth 5YN/A
Sales Q2Q%-4.96%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NBXG Yearly Revenue VS EstimatesNBXG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

NBXG is valuated reasonably with a Price/Earnings ratio of 9.88.
Compared to an average S&P500 Price/Earnings ratio of 27.86, NBXG is valued rather cheaply.
Industry RankSector Rank
PE 9.88
Fwd PE N/A
NBXG Price Earnings VS Forward Price EarningsNBXG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 13.08
EV/EBITDA N/A
NBXG Per share dataNBXG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.12%, NBXG is a good candidate for dividend investing.
NBXG's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 7.12%

5.2 History

NBXG has been paying a dividend for over 5 years, so it has already some track record.
NBXG has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
NBXG Yearly Dividends per shareNBXG Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

NBXG pays out 76.55% of its income as dividend. This is not a sustainable payout ratio.
DP76.55%
EPS Next 2YN/A
EPS Next 3YN/A
NBXG Yearly Income VS Free CF VS DividendNBXG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 0 200M -200M -400M -600M
NBXG Dividend Payout.NBXG Dividend Payout, showing the Payout Ratio.NBXG Dividend Payout.PayoutRetained Earnings

More info and screens

NBRGR BRMN NEX GEN CONNECT

NYSE:NBXG (10/6/2025, 10:55:38 AM)

15.61

+0.15 (+0.97%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners40.47%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner Change0%
Market Cap1.23B
Analysts0
Price TargetN/A
Short Float %0.12%
Short Ratio0.57
Dividend
Industry RankSector Rank
Dividend Yield 7.12%
Yearly Dividend1.2
Dividend Growth(5Y)N/A
DP76.55%
Div Incr Years0
Div Non Decr Years3
Ex-Date09-15 2025-09-15 (0.1)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 9.88
Fwd PE N/A
P/S 111.77
P/FCF 13.08
P/OCF 13.08
P/B 1.13
P/tB 1.13
EV/EBITDA N/A
EPS(TTM)1.58
EY10.12%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.19
FCFY7.65%
OCF(TTM)1.19
OCFY7.65%
SpS0.14
BVpS13.86
TBVpS13.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.31%
ROE 11.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1128.18%
GM N/A
FCFM 854.55%
ROA(3y)-9.77%
ROA(5y)N/A
ROE(3y)-10.25%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-5.1%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 75.75%
Current Ratio 0.03
Quick Ratio 0.03
Altman-Z 134.35
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-39.92%
EPS 3Y41.88%
EPS 5YN/A
EPS Q2Q%-100.93%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.42%
Revenue growth 3Y49.53%
Revenue growth 5YN/A
Sales Q2Q%-4.96%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-38.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y3.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3.3%
OCF growth 3YN/A
OCF growth 5YN/A